Cartilage Remodeling Using Low-Temperature Radiofrequency for Nasal Airway Reconstruction
NCT ID: NCT07032675
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-10-14
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. How many LTRF treatments are needed to achieve the desired shape in a given cartilage specimen
2. How does an LTRF treatment quantitatively affect both length and angulation of a cartilage specimen
3. How does physician satisfaction with cosmetic outcome compare to cases treated with existing septorhinoplasty techniques
4. How do changes in patient reported measures of nasal obstruction (NOSE score) pre- and post-surgery compare to cases treated with existing septorhinoplasty techniques
5. Does using LTRF during septorhinoplasty significantly increase total operative time
6. Are rates of adverse events when using LTRF different from cases treated with existing septorhinoplasty techniques
Participants will complete the NOSE questionnaire at their pre-operative visit. Participants undergoing cosmetic septhorhinoplasty will also be photographed in standard fashion for facial analysis.
During scheduled septorhinoplasty surgery, the Vivaer LTRF device will be used to reshape nasal and/or auricular cartilage ex-vivo prior to reimplantation at the discretion of the Principal Investigator in order to optimize functional and cosmetic outcome.
Participants will follow up at approximately 1 week and 1 month after surgery. At 1 month, the NOSE questionnaire will be readministered to all participants, and cosmetic patients will be photographed again.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluate the Effectiveness of the Vivaer ARC Stylus for Nasal Breathing
NCT04717791
A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.
NCT06922955
VivAer: A Correlation Between Symptom Scores and Objective Findings
NCT05573919
Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study
NCT04549545
Efficacy And Safety of An IRE System For Treatment of Inferior Turbinate Hypertrophy
NCT06438185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-temperature radio-frequency reshaping intervention
All enrolled subjects will receive the intervention outlined in the section titled "Study Design".
Low-temperature radio-frequency reshaping of autologous cartilage nasal and/or auricular cartilage
The device settings will be set per the manufacturer's instructions: temperature = 60° C, power = 4 W, treatment time = 18 seconds, and cooldown = 12 seconds. For curved-to-straight (CTS) samples (natively curved cartilage to be remolded to be flat), the cartilage specimens will be placed on a blue towel on a flat surface with the transmission medium over top and treated. For straight-to-curved (STC) samples (natively flat cartilage to be remolded to be curved), cartilage specimens will be placed along the inner surface of various shallow, plastic, cylindrical objects with the transmission medium over top and treated. Various device settings may be tested for reshaping efficacy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-temperature radio-frequency reshaping of autologous cartilage nasal and/or auricular cartilage
The device settings will be set per the manufacturer's instructions: temperature = 60° C, power = 4 W, treatment time = 18 seconds, and cooldown = 12 seconds. For curved-to-straight (CTS) samples (natively curved cartilage to be remolded to be flat), the cartilage specimens will be placed on a blue towel on a flat surface with the transmission medium over top and treated. For straight-to-curved (STC) samples (natively flat cartilage to be remolded to be curved), cartilage specimens will be placed along the inner surface of various shallow, plastic, cylindrical objects with the transmission medium over top and treated. Various device settings may be tested for reshaping efficacy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who have received prior head and neck radiation
* Patients with a septal perforation
* Patients who are medically ineligible to undergo septorhinoplasty.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taha Shipchandler
Division Chief of Facial Plastic and Reconstructive Surgery in the Department of Otolaryngology-Head and Neck Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IU Health Methodist Hospital
Indianapolis, Indiana, United States
IU Health North Hospital
Indianapolis, Indiana, United States
IU Health Saxony Hospital
Indianapolis, Indiana, United States
IU Health University Hospital
Indianapolis, Indiana, United States
IU Health West Hospital
Indianapolis, Indiana, United States
Riley Hospital for Children at IU Health
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mitchell Victor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24964
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.